Jennifer Straumins - Dec 18, 2024 Form 4 Insider Report for Calumet, Inc. /DE (CLMT)

Role: Director
Signature: /s/ Vincent Donargo, as attorney-in-fact
Stock symbol: CLMT
Transactions as of: Dec 18, 2024
Transactions value $: -$810,983
Form type: 4
Date filed: 12/20/2024, 01:20 PM
Previous filing: Dec 5, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CLMT	Common Stock, par value $0.01 per share	Sale	-$811K	-37.9K	-3.1%	$21.42	1.18M	Dec 18, 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On July 10, 2024, in connection with the corporate reorganization of Calumet Specialty Products Partners, L.P. (the "Partnership"), pursuant to which the Partnership converted from a master limited partnership to a corporation (the "Conversion"), Calumet Merger Sub I LLC merged with and into Calumet GP, LLC, the general partner (the "General Partner") of the Partnership, with the General Partner continuing as the surviving entity and a wholly owned subsidiary of Calumet, Inc. (the "GP Merger"). In connection with the GP Merger, the reporting person was issued 825,000 shares of Calumet, Inc. common stock, par value $0.01 per share ("Common Stock"), and 300,000 warrants to purchase Common Stock. The reporting person sold the 37,861 shares of Common Stock reported herein to offset a portion of her tax obligations that were incurred as a result of the Conversion transaction.

Content

On July 10, 2024, in connection with the corporate reorganization of Calumet Specialty Products Partners, L.P. (the "Partnership"), pursuant to which the Partnership converted from a master limited partnership to a corporation (the "Conversion"), Calumet Merger Sub I LLC merged with and into Calumet GP, LLC, the general partner (the "General Partner") of the Partnership, with the General Partner continuing as the surviving entity and a wholly owned subsidiary of Calumet, Inc. (the "GP Merger"). In connection with the GP Merger, the reporting person was issued 825,000 shares of Calumet, Inc. common stock, par value $0.01 per share ("Common Stock"), and 300,000 warrants to purchase Common Stock. The reporting person sold the 37,861 shares of Common Stock reported herein to offset a portion of her tax obligations that were incurred as a result of the Conversion transaction.